Atlas Venture Fund XI, L.P.
SEC CIK 1708269 · EDGAR
BoughtSold
Most active insiders at SION, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Thompson Peter A. | Dir | — | $55.67M |
| 2 | ORBIMED ADVISORS LLC | Dir | — | $52.73M |
| 3 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | — | $27.34M |
| 4 | Booth Bruce | Dir | — | $22.09M |
| 5 | RA Capital Nexus Fund III, L.P. | Dir | — | $14.76M |
| 6 | WINKELRIED JON | 10% | — | $10.00M |
| 7 | Cloonan Michael | Pres, CEO, Dir | — | $5.13M |
| 8 | OrbiMed Capital GP VIII LLC | Dir | — | $2.95M |
| 9 | Fitzpatrick Jennifer | CLO, Head of Program Mgmt | — | $1.21M |
| 10 | Kolchinsky Peter | Dir, 10% | — | $1.20M |
Atlas Venture Fund XI, L.P. made no open-market trades at SION in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-02-10 | 2025-02-10 | SION | Sionna Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% | P - Purchase | $18.00 | +60.0K | 807.7K | +8% | +$1.08M |
| DI | 2025-02-10 | 2025-02-10 | SION | Sionna Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% | C - Cnv Deriv | — | +747.7K | 747.7K | New | — |
| D | 2025-02-10 | 2025-02-10 | SION | Sionna Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% | C - Cnv Deriv | — | +2.89M | 2.89M | New | — |
| I | 2024-02-09 | 2024-02-08 | XLO | Xilio Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% | S - Sale | $0.64 | -267 | 734.5K | -0.0% | -$170.88 |
| 2024-02-09 | 2024-02-08 | XLO | Xilio Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% | S - Sale | $0.64 | -733 | 2.02M | -0.0% | -$469.12 | |
| 2021-07-15 | 2021-07-13 | DYN | Dyne Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% | J - Other | $0.00 | -814.0K | 7.33M | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations